Feed CRON
CR

Cronos Group Inc. CRON · NASDAQ

$3.21 +0.31% (+$0.01)

Market cap
$1.18B
Enterprise value
$713.2M
P/E
16.9x
Forward P/E
19.4x
PEG
-
P/S
4.9x
P/FCF
26.5x
EV/EBITDA
29.3x
ROIC
1.3%
Gross margin
33.5%
Net margin
28.7%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-19.1x
Beta
1.20
Free float
50.8%

About the company

Cronos Group Inc. (CRON) is a Canadian company operating in the legal cannabis industry and cannabis-based products. The company specializes in cultivating and producing cannabis for medical and recreational purposes. Cronos Group has a global presence and operates in several countries where cannabis and its products are legal. The company offers a wide range of products, including dried cannabis, oils, tinctures, vaporizer cartridges, and other consumer products based on cannabis. Cronos Group Inc. closely monitors regulations and laws related to legal cannabis in various countries and strives to maintain the highest standards of quality and safety for its products. Shares of Cronos Group Inc. (CRON) can present an interesting investment opportunity for investors following the growing market of legal cannabis and its products.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Michael Ryan Gorenstein

Employees

610

Headquarters

Stayner

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.